PerioVive draws attention as HA adjunct in veterinary dentistry
Bottom line
Version 1
PerioVive, a veterinary-formulated hyaluronic acid gel positioned as an adjunct for dental procedures in dogs and cats, is getting fresh attention through dvm360 coverage and a Vet Blast podcast featuring the company’s chief veterinary officer, Elizabeth Wright Smith, DVM, MS. The product is marketed for use after periodontal and oral surgical procedures, with company materials saying a single application supports healing, reduces irritation, and promotes tissue regeneration. That message is backed, in part, by a recent review in the Journal of Veterinary Dentistry that found preclinical dog studies showing benefit for hyaluronic acid as an adjunct to periodontal procedures, while also noting there are still no clinical studies in veterinary patients with naturally occurring periodontal disease. (periovive.com)
Why it matters: Periodontal disease is one of the most common problems seen in small animal practice, so any adjunct that may improve healing after extractions, flap procedures, root planing, or management of furcation defects will draw interest. For veterinary professionals, the key point is that the current evidence base appears strongest in experimental dog models and broader human dentistry literature, not in large, controlled clinical trials in pet patients. The published review also stresses that hyaluronic acid should be used as an adjunct to thorough debridement, not a replacement for standard dental care, which keeps expectations grounded for case selection and client communication. (journals.sagepub.com)
What to watch: Watch for peer-reviewed clinical studies in dogs and cats with naturally occurring disease, as well as clearer data on which procedures and case types benefit most. (journals.sagepub.com)
Key facts
- Product
- PerioVive
- Formulation
- Veterinary-formulated hyaluronic acid gel
- Use
- Adjunct after periodontal and oral surgical procedures in dogs and cats
- Claimed effects
- Supports healing, reduces irritation, and promotes tissue regeneration
- Evidence base
- Preclinical dog studies and broader human dentistry literature
- Review finding
- No clinical studies in veterinary patients with naturally occurring periodontal disease
- Study model
- Five research-setting studies in adult beagle dogs
- Potential procedures
- Scaling and root planing, open flap debridement, guided tissue regeneration, and post-extraction healing
Version 2
PerioVive is being promoted as a regenerative add-on for veterinary dentistry, with recent dvm360 coverage and podcast discussion spotlighting the company’s hyaluronic acid gel for use across routine and advanced dental procedures in dogs and cats. Company materials describe it as a pre-filled, veterinary-formulated hyaluronic acid applicator intended for placement after procedures to support healing, reduce irritation, and promote tissue regeneration. (periovive.com)
The interest here comes from a familiar clinical problem: periodontal disease is widespread in companion animals, and veterinary teams are always looking for ways to improve healing after periodontal therapy and oral surgery. PerioVive’s positioning also fits a larger trend in dentistry toward local adjuncts that may improve tissue response without standing in for the basics of care. The American Veterinary Dental College’s antibiotic guidance, for example, emphasizes that adjunctive therapies should not replace definitive treatment of oral disease. (journals.sagepub.com)
What’s new is less a regulatory milestone than a visibility push around the product and its evidence story. PerioVive’s website says the gel is already being used in specialty dental practices and distributed through veterinary channels in the US and internationally. The company’s science page points to studies in dogs involving intrabony defects, extraction sockets with chronic pathology, and class II furcation defects, all areas where regenerative support could matter clinically. (periovive.com)
The most useful independent context comes from a 2026 review article in the Journal of Veterinary Dentistry by Bryan Song, MD, PerioVive’s founder and CEO. That review says five research-setting studies in adult beagle dogs showed benefits for hyaluronic acid as a monotherapy adjunct to periodontal procedures across multiple endpoints. It also concludes that hyaluronic acid has potential to improve outcomes in scaling and root planing, open flap debridement, guided tissue regeneration, post-extraction healing, and possibly stomatitis cases, while clearly acknowledging that there are no clinical studies in veterinary medicine evaluating hyaluronic acid for naturally occurring periodontal disease. The paper also discloses company funding and the author’s leadership role, which is important context when weighing the claims. (journals.sagepub.com)
The underlying preclinical literature is encouraging, but still narrow. In one 2021 dog study, cross-linked hyaluronic acid alone or with a collagen matrix produced significantly greater new attachment than open flap debridement alone in surgically created intrabony defects. In a 2023 dog study of class II furcation defects, hyaluronic acid with or without acellular dermal matrix allograft improved new bone, cementum, and periodontal ligament formation versus open flap debridement, with the combination arm performing best at three months. Those are meaningful signals for regenerative dentistry, but they come from controlled beagle models rather than everyday referral or general practice patients. (pubmed.ncbi.nlm.nih.gov)
Industry reaction so far appears to be strongest from within dental specialty circles and company-sponsored education. PerioVive’s site includes a testimonial from Pet Dental USA saying its clinics have switched to the product for many procedures, and the company is using webinars and CE-style programming to position hyaluronic acid as a local periodontal adjunct. That suggests early commercial traction, but it’s not the same as independent post-market outcomes research. (periovive.com)
Why it matters: For veterinary professionals, PerioVive sits at the intersection of two realities: a huge burden of periodontal disease in practice, and a limited menu of evidence-backed local regenerative adjuncts. If hyaluronic acid can reliably improve soft tissue healing, reduce inflammation, and support regeneration after extractions or periodontal surgery, it could become a useful tool for dentists and, eventually, for high-dental-volume general practices. But right now, the most defensible takeaway is that the product is promising, biologically plausible, and supported by preclinical and extrapolated human literature, not yet by robust clinical trials in pet patients with naturally occurring disease. (journals.sagepub.com)
That distinction matters for how teams talk to pet parents. Practices considering adoption will likely want to weigh cost, ease of use, procedure fit, and whether the product improves outcomes enough to justify routine use. They’ll also want to avoid overstating the evidence, especially in chronic inflammatory conditions such as feline gingivostomatitis or canine chronic ulcerative stomatitis, where the current support appears to be more inferential than directly proven in veterinary trials. (journals.sagepub.com)
What to watch: The next meaningful step is peer-reviewed clinical data in dogs and cats seen in real-world practice, especially studies that compare outcomes after extractions, periodontal pocket therapy, furcation management, and chronic oral inflammatory disease treatment. (journals.sagepub.com)